Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2026-04-07 @ 1:02 PM
Study NCT ID:
NCT07297602
Status:
RECRUITING
Last Update Posted:
2025-12-22
First Post:
2025-12-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study
Sponsor:
Nora Mohamed Abdelrazik
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
R.25.11.3442.R1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |